🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementPancreatitis risk assessment — anyone have experience? Page 4

Pancreatitis risk assessment — anyone have experience?

JenPlateau Wed, Jul 2, 2025 at 6:56 PM 29 replies 1,958 viewsPage 4 of 6
JakeBK_lifts
Member
523
2,345
Jul 2024
Brooklyn, NY
Jul 9, 2025 at 2:30 PM#16
anders_CPH said:
The version of this that has an answer is narrower than the version being asked.

Same pattern here, and in the same order.

27 0TrialTracker_MD, JennaRN, LabKate and 24 others
Reply Quote Save Share Report
HealthEcon_DC
Member
567
3,456
Apr 2024
Washington, DC
Jul 10, 2025 at 5:50 AM#17

One thing that is still open after KevinCompounds’s answer:

Did your prescriber agree with that reading, and if not what was their objection?

28 1JessicaH_TX, KevinCompounds, TirzTom and 25 others
Reply Quote Save Share Report
tane_welly
Member
234
1,123
Sep 2024
Wellington, NZ
Jul 10, 2025 at 9:10 PM#18
DoseLogDan said:
Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a…

I do not accept the framing. The question has been narrowed to the version that has a tidy answer, and the part that was dropped is the part the OP actually asked about.

29 2DanielChem_CHI, marco_milano, pam_columbus and 26 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
BethLabQueen
Senior Member
1,234
5,678
May 2024
Virginia
Online
Jul 11, 2025 at 12:30 PM#19
DoseLogDan said:
Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a…

Correct as far as it goes. The part it does not cover is what to do when the honest answer is "not enough data", which is more often than anyone likes.

30 3cory_ATX, lori_vegas, Dr.PulmRoch and 27 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Jul 12, 2025 at 3:49 AM#20

Moderator note: good thread. Keeping it here rather than moving it, because the question is general enough to be useful. Report rather than reply if it drifts again.

2 0PurityPaulOR, MaxMetOK
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register